Carbapenem-resistant Enterobacterales/Enterobacteriaceae (CRE) in Indonesia: protocol for systematic review and meta-analysis

TL;DR

This study will review and analyze the prevalence of carbapenem-resistant bacteria in Indonesia to understand their spread and resistance patterns.

Contribution

The study will provide the first comprehensive overview of CRE prevalence in Indonesia through a systematic review and meta-analysis.

Findings

Estimates pooled prevalence of carbapenem-resistant Enterobacterales in Indonesia.

Identifies key resistance mechanisms and trends over time.

Highlights geographical and healthcare setting variations in CRE prevalence.

Abstract

Carbapenem-resistant Enterobacterales (CRE) pose a significant global health threat, with increasing prevalence worldwide, including in Indonesia. Despite the public health impact, comprehensive data on the burden of CRE in Indonesia remains fragmented. This protocol outlines a systematic review and meta-analysis aiming to estimate the prevalence of CRE in Indonesia, summarize trends over time, and identify key resistance mechanisms.

We will conduct a systematic search across multiple electronic databases, including PubMed, Scopus, and local Indonesian databases, for studies reporting the prevalence of CRE in Indonesia from 2008 to 2024. Eligibility criteria include observational studies (cross-sectional, cohort, and case-control) and surveillance reports. Data extraction will focus on CRE prevalence, bacterial species, sample types, resistance mechanisms, and study settings (hospital vs. community). Quality assessment of studies will be performed using the Newcastle-Ottawa Scale (NOS). Meta-analysis will be conducted using a random-effects model to estimate pooled prevalence, and subgroup analysis will explore variations by geographical region, period, and healthcare setting.

This systematic review and meta-analysis will provide the first comprehensive overview of CRE prevalence in Indonesia, contributing to an improved understanding of the national burden and resistance patterns. The findings will guide public health policies and inform antimicrobial stewardship efforts in Indonesia.

PROSPERO CRD42024580177